Skip to main content
Log in

Isolation and purification of uremic middle molecules by multi-step liquid chromatography

  • Published:
Science in China Series B: Chemistry Aims and scope Submit manuscript

Abstract

Isolation and comparison of uremic sera and urine and normal sera and urine were performed by gel permeation chromatography, anion exchange chromatography and reversed-phase high performance liquid chromatography. Two uremic middle molecular fractions (A and B) were obtained from uremic sera and urine and normal urine by gel permeation chromatography, but not from normal sera. The anion exchange chromatographic results of fraction A from different origins demonstrate that subfraction A-3 could be excreted in urine by healthy subject, but accumulated in uremic serum for renal failure of patient with uremia. After desalinization subfraction A-3 was analyzed by MALDI-TOF-MS. The results show that subfraction A-3 consists of six compounds with molecular weight 839, 873, 1007.94, 1106, 1680 and 2015 respectively. Finally, by reversed-phase high performance liquid chromatography, subfraction A-3 was further resolved into six independent fractions. Thus, the isolation and purification of six middle molecular compounds in subfraction A-3 came true by our method.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Remond, V., Reta, D., Chen, H. et al., Uremic toxicity: the middle molecule hypothesis resisted, Seminars in Nephrol., 1994, 14(3): 205–218.

    Google Scholar 

  2. Remond, V., Reta, D., Psascale, V. et al., Middle molecules: toxicity and removal by hemodialysis and related strategies, Artif. Organs, 1995, 19(11): 1120–1125.

    Article  Google Scholar 

  3. Gallice, P., Monti, J. P., Braguer, D. L. et al., Identification of an ascorbic acid metabolite among “uremic middle molecules”, Clin. Chem., 1990, 36(7): 1369–1372.

    CAS  Google Scholar 

  4. Abiko, T., Onodera, T., Sekino, H. et al., Apeptide isolation from the hemodialysate of a uremic patient with immunodeficiency inhibits lymphocyte stimulation, J. Appl. Biochem., 1981, 3: 562–569.

    Google Scholar 

  5. Wu Zhaolong, Liao Yutan, Cai Juhui et al., Biological activity of middle molecules from serum of patients with uremia, Chinese Journal of Pathophysiology, 1995, 11(1): 90–94.

    CAS  Google Scholar 

  6. Yuan Zhi, Zhang Ji, Zhao Fenzhi et al., Extraction and primary analysis of uremic middle molecular substance, Chem. J. Chin. Uni., 1989, 10(4): 401–405.

    Google Scholar 

  7. Chapman, G. V., Ward, R. A., Frrel, P. C. et al., Separation and quantification of “the middle molecules” in uremia, Kidney Int., 1980, 17: 82–88.

    Article  CAS  Google Scholar 

  8. Chu Jiegen, Yuan Zhi, Mi Huaifeng et al., Isolation and analysis of middle molecular substances from uremic serum and normal urine, Science in China, Series B (in Chinese), 2000, 30(3): 250–255.

    Google Scholar 

  9. Fürst, P., Zimmerman, L., Bergstrom, J., Determination of endogenous middle molecules in normal and uremic body fluids, Clin. Nephrol., 1976, 5(4): 178–188.

    Google Scholar 

  10. Gibson, T. P., Matusk, E., Nelson, L. D. et al., Artifical kidneys and clearance calculations, Clin. Pharmacol. Ther., 1976, 20: 720–726.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi Yuan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chu, J., Liu, X., Yuan, Z. et al. Isolation and purification of uremic middle molecules by multi-step liquid chromatography. Sc. China Ser. B-Chem. 45, 225–231 (2002). https://doi.org/10.1360/02yb9030

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1360/02yb9030

Keywords

Navigation